BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 10699951)

  • 1. High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines.
    Hurks HM; Metzelaar-Blok JA; Mulder A; Claas FH; Jager MJ
    Int J Cancer; 2000 Mar; 85(5):697-702. PubMed ID: 10699951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA antigen expression on uveal melanoma cells in vivo and in vitro.
    de Waard-Siebinga I; Kool J; Jager MJ
    Hum Immunol; 1995 Oct; 44(2):111-7. PubMed ID: 8847229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA expression in uveal melanoma: there is no rule without some exception.
    Jager MJ; Hurks HM; Levitskaya J; Kiessling R
    Hum Immunol; 2002 Jun; 63(6):444-51. PubMed ID: 12039519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.
    Rodríguez T; Méndez R; Del Campo A; Aptsiauri N; Martín J; Orozco G; Pawelec G; Schadendorf D; Ruiz-Cabello F; Garrido F
    Immunogenetics; 2007 Feb; 59(2):123-33. PubMed ID: 17180681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
    Maio M; Gulwani B; Morgano A; Ferrone S
    Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of interferon alfa and gamma on human uveal melanoma cells in vitro.
    de Waard-Siebinga I; Creyghton WM; Kool J; Jager MJ
    Br J Ophthalmol; 1995 Sep; 79(9):847-55. PubMed ID: 7488605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uveal melanoma: no expression of HLA-G.
    Hurks HM; Valter MM; Wilson L; Hilgert I; van den Elsen PJ; Jager MJ
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3081-4. PubMed ID: 11726606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion.
    Chen PW; Mellon JK; Mayhew E; Wang S; He YG; Hogan N; Niederkorn JY
    Exp Eye Res; 2007 Nov; 85(5):617-25. PubMed ID: 17870068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles.
    Pende D; Accame L; Pareti L; Mazzocchi A; Moretta A; Parmiani G; Moretta L
    Eur J Immunol; 1998 Aug; 28(8):2384-94. PubMed ID: 9710216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
    Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of HLA-DR gene expression induced by IFN-gamma in malignant melanoma cell lines.
    Lee JL; Kim YH; Lee JM; Kim JD; Kim SJ; Park JH
    Yonsei Med J; 1999 Feb; 40(1):30-9. PubMed ID: 10198604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal HLA class I, II, and MICA gene distribution in uveal melanoma.
    Metzelaar-Blok JA; Hurks HM; Naipal A; De Lange P; Keunen JE; Claas FH; Doxiadis II; Jager MJ
    Mol Vis; 2005 Dec; 11():1166-72. PubMed ID: 16379028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
    Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
    Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decitabine up-regulates S100A2 expression and synergizes with IFN-gamma to kill uveal melanoma cells.
    Gollob JA; Sciambi CJ
    Clin Cancer Res; 2007 Sep; 13(17):5219-25. PubMed ID: 17785578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulatory molecule expression on human uveal melanoma cells: functional analysis of CD40 and B7-H1.
    Ma J; Usui Y; Kezuka T; Okunuki Y; Zhang L; An X; Mizota A; Goto H
    Exp Eye Res; 2012 Mar; 96(1):98-106. PubMed ID: 22200489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.
    Beniers AJ; Peelen WP; Debruyne FM; Schalken JA
    Int J Cancer; 1991 Jul; 48(5):709-16. PubMed ID: 1906431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-L1: PD-1 interaction contributes to the functional suppression of T-cell responses to human uveal melanoma cells in vitro.
    Yang W; Chen PW; Li H; Alizadeh H; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2518-25. PubMed ID: 18296654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
    Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
    BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose IFN-gamma induces tumor MHC expression in metastatic malignant melanoma.
    Propper DJ; Chao D; Braybrooke JP; Bahl P; Thavasu P; Balkwill F; Turley H; Dobbs N; Gatter K; Talbot DC; Harris AL; Ganesan TS
    Clin Cancer Res; 2003 Jan; 9(1):84-92. PubMed ID: 12538455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumour-cell variants expressing a single HLA-class-I allele.
    Real LM; Jimenez P; Cantón J; Kirkin A; García A; Abril E; Zeuthen J; Ruiz-Cabello F; Garrido F
    Int J Cancer; 1998 Jan; 75(2):317-23. PubMed ID: 9462725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.